| Patent application number | Description | Published |
|---|
| 20100221616 | NON-AQUEOUS CELL HAVING AMORPHOUS OR SEMI-CRYSTALLINE COPPER MANGANESE OXIDE CATHODE MATERIAL - The present disclosure relates generally to a high capacity cathode material suitable for use in a non-aqueous electrochemical cell that comprises copper manganese oxide, which may be in amorphous or semi-crystalline form, and optionally fluorinated carbon. The present disclosure additionally relates to a non-aqueous electrochemical cell comprising such a cathode material and, in particular, to such a non-aqueous electrochemical cell that can deliver a higher capacity than conventional cell. | 09-02-2010 |
| 20100310907 | END OF LIFE INDICATION SYSTEM AND METHOD FOR NON-AQUEOUS CELL HAVING AMORPHOUS OR SEMI-CRYSTALLINE COPPER MANGANESE OXIDE CATHOD MATERIAL - The present disclosure relates generally to indicating an end of life condition of an electrochemical device, and more particularly to systems and methods for sensing and determining an end of life condition in a cell comprising a high capacity cathode material suitable for use in a non-aqueous electrochemical cell. The high capacity cathode material has an amorphous or semi-crystalline form of copper manganese oxide, and optionally fluorinated carbon. The present disclosure additionally relates to transmitting the determined end of life condition to a user or monitoring device of the cell. | 12-09-2010 |
| 20100310908 | NON-AQUEOUS ELECTROCHEMICAL CELL HAVING A MIXTURE OF AT LEAST THREE CATHODE MATERIALS THEREIN - The present disclosure relates generally to a high capacity cathode material suitable for use in a non-aqueous electrochemical cell that comprises a mixture of at least three different cathode materials, and more specifically a mixture of fluorinated carbon, an oxide of copper and an oxide of manganese. The present disclosure additionally relates to a non-aqueous electrochemical cell comprising such a cathode material and, in particular, to such a non-aqueous electrochemical cell that can deliver a higher capacity than a conventional cell, and/or that possesses an improved end-of-life indication. | 12-09-2010 |
